Program Budget & Timeline Executive Plan
PARTNER WITH OUR ONCOLOGY- FOCUSED REGULATORY EXPERTS for accurate planning
TD2’s expert drug development team offers executive-level consultation as you begin transitioning your oncology therapy from preclinical research to the Clinic. Our experienced team will prepare and provide an estimated budget and timeline for your program, so you can plan for the most critical pre-IND activities and, ultimately, getting the first patient enrolled.
- Set realistic expectations at your next investor or board meeting with well-informed timeline and budget projections.
- Mitigate risk and avoid delays as you prepare to file your IND application by planning early.
Whether your novel therapy is a cell or gene therapy, a small molecule, or a peptide, we can tailor a plan for you. The Executive Plan will provide you with:
- Consultation Session with our Senior Regulatory team
- 5-Slide presentation deck that includes:
- Summary of the current status of your therapy
- High Level Timeline
- High Level Budget
- Commentary from our experts
- Suggested Next Steps
Interested in a more detailed program plan? Our Gap Analysis services can provide you with a precise step-by-step roadmap for all pre-IND required activities needed for your therapy.